Stephen Lemieux - 04 Aug 2023 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Chief Financial Officer
Signature: /s/ Stephen Lemieux
Issuer symbol: EDSA
Transactions as of: 04 Aug 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Aug 2023, 16:19:03 UTC
Previous filing: 24 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDSA	Common Shares	Award		+17,400			17,400	04 Aug 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of certain compensation fees earned by Reporting Person. The number of RSUs was determined by dividing such fees by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.

Content

Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of certain compensation fees earned by Reporting Person. The number of RSUs was determined by dividing such fees by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.